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Abstract 
Medication errors are a constant source of strife to both patients and healthcare providers 
alike since time immemorial. Regardless of our level of technology, the fallible nature of humans 
makes medication errors a common occurrence in healthcare. One type of medication error that 
can often be overlooked is the omission error. An omission error occurs when a patient does not 
receive a medication without a justification for that omission. 
Few healthcare providers would argue that medication errors do not contribute greatly to 
hospitalization costs. Unfortunately, because most medication errors are reported on a voluntary 
basis, it is extremely difficult to accurately estimate the total cost (Choi, Lee, Flynn, Kim, Lee, 
Kim, & Suh, 2016). Estimates vary widely and are often unique to the healthcare system that 
they occur in due to methodology used to classify and study the data (Choi et al., 2016). Few 
data exist on medication omission errors (MOEs) exclusively, despite this type of error being one 
of the most common kind of errors (Grissinger, 2017). Two prior literature reviews on 
medication errors found multiple contradictory causes, however, some common themes will be 
explored in this review (Lassetter & Warnick, 2003; Berdot et al., 2015). This discussion and 
literature review examines the existing data on the causes, and the costs associated with 
medication omission errors. 
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The Cost and Causes of Medication Omission Errors: A Discussion and Literature Review 
Medication errors plague the United States (U.S.) healthcare system. The mean number 
of medication error-related sentinel events reported by The Joint Commission (2018) over the 
last four years is 33.5 per year, with a fluctuating course of increases and decreases.  A sentinel 
event is defined as an event that causes, or has the potential to cause, severe injury, impairment, 
or death (The Joint Commission, n.d.).  Despite increased public and media attention since the 
publishing of the Institute of Medicine’s (IOM) ‘To Err is Human: Building a Safer Health 
System’ in 1999, the rates of medication errors have remained high, and indeed remain the most 
frequent cause of patient harm in hospitals (Parry, Barriball, & While, 2014, p. 404).  A follow up 
study by the IOM in 2006 entitled ‘Preventing Medication Errors’ noted that medication errors 
cause harm to 1.5 million patients a year in the US alone, and cost somewhere in the realm of 
$3.5 billion U.S. annually (Riaz, Riaz & Latif, 2017, p. 921). 
The purpose of this paper is to examine types of medication errors with a focus on 
medication omission errors (MOEs). Reasons for why MOEs are difficulty to study will be 
provided. Costs and causes of MOEs will be described as well. Finally, a discussion, including 
recommendations to prevent MOEs, will be offered.  
Types of Medication Errors 
 A medication error can occur at any stage of the medication use process: ordering, 
transcribing, dispensing, and administration (American Society of Hospitalist Pharmacists, 
2018). Within these four categories there are a plethora of subcategories. Beyond this, 
medication errors may occur at any stage of hospitalization; everything from the storage of the 
medication to how it is packaged may be contributive to an error. The American Society of 
Hospital Pharmacists (ASHP), publishes exhaustive guidelines to definitions, types of errors, and 
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methods for reducing errors yearly (ASHP, 2018).  For the sake of this paper, we will mostly be 
examining the administration aspect of medication errors. 
Multiple studies have noted that administration errors are the most common type of 
medication error (Berdot, 2016; Choi et al., 2016; Fitzhenry et al., 2007; Parry et al., 2015; Scott, 
Considine, & Botti, 2014; Tyynismaa, Honkala, Airaksinen, Shermock, & Lehtonen, 2017), with 
omission errors being the most common type of administration cited in multiple sources 
(Fitzhenry et al., 2007; Grissinger, 2017; Scott et al., 2014).   
According to Grissinger (2017), “drug omission can be defined as an event in which a 
medication is not provided to a patient, because the medication has either not been prescribed or 
has not been administered” (p. 66).  Put even more simply, a drug omission error occurs when a 
patient needs to receive is not administered for any myriad of reasons. 
One can extrapolate from this information, that medication administration errors, and 
MOEs in particular, are common.  In fact, Grissinger (2017), notes that MOEs affect up to 17% 
of patients, and possibly even 20% of all medications prescribed in an acute care setting (p. 66).   
Of these MOEs, many are related to high-risk medications.  In one study as high as 24% of 
unexcused omissions involved high risk medications (Munzner, Welch & Richardson, 2012).  In 
fact, very commonly administered medications are in the top five high-risk medications that 
result in patient harm such as anticoagulants, antibacterials, and antipsychotics (Newbould, 
Meur, Goedecke & Kurz, 2017; Tyynismaa et al., 2017). 
Choi et al. (2016), mentions that $3.5 billion is spent on medication errors annually (p. 
428). These costs are not just related to increased length of stay or acute care costs.  They also lie 
within the time and resources diverted to correcting medication errors that do not cause any 
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patient harm (Choi et al., 2016).  With MOEs affecting so many and costing so much money, 
why does such little data exist on this issue?   
Difficulty of Studying Omission Errors 
There are multiple reasons that MOE’s are difficult to study.  Some reasons seem 
obvious, but others less conspicuous.  In this section, reasons including cost of direct observation 
studies, legal issues, classification of errors, and error reporting will be examined. 
Direct Observation Studies 
Berdot et al. (2016) wrote a systematic review of medication administration errors and 
concluded that direct observation methods are the gold standard of study design for accurate 
representation of medication errors. Out of 5,306 studies identified, by Berdot et al. (2016), only 
7 studies met this gold standard (p. 344).  Additionally, Berdot et al. (2016), noted that nearly all 
medication error studies “had a high risk of bias in at least one domain.  The most common 
source of bias risk was a lack of blinding to outcome” (p. 345).   
Direct observation studies utilize trained personnel (often pharmacy students) to follow 
healthcare staff and directly witness and record medication administration, typically under the 
guise of doing some other task to minimize the Hawthorn effect (Berdot et al., 2016). This is 
obviously costly, requires a lot of permissions, and is limited in scope each time. 
Legal Issues 
Although anecdotally mentioned in multiple articles something that certainly warrants 
further attention, is the effect of litigation or threat of litigation on research in this area (Lassetter 
& Warnick, 2003; Newbold et al., 2017; Wolf, 2016). One study specifically mentions having 
litigation possibly skewing their data pool (Newbold et al., 2017). Interestingly, this litigation 
wariness was not only present in American studies (Wolf, 2016), but was also featured in 
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European studies (Newbold et al., 2017).  Unfortunately, the actual impact of litigation or fear of 
litigation on research in this area is not expanded upon.  How much data may be excluded by 
pending litigation or sealed medical records is also unclear. 
Classification of Errors 
Another common issue that this author encountered is the plethora of categories in which 
medication errors are divided up. While there are common themes and agreements on general 
categories, multiple researchers with multiple methods of study, have multiple categories of 
medication errors that may or may not fit anyone else’s design.  Specifically, when it comes to 
MOEs, much of these omissions are not considered true errors if they can be rationally explained 
secondary to patient refusal, contraindication, or clinical decision making at the sharp-end of 
treatment (Coleman, McDowell & Ferner, 2012).  However, as any healthcare provider can attest 
to, not all decisions made at the administration point of treatment are correct.  In these instances, 
if a medication is omitted for whatever reason, it falls under the definition of an MOE, although 
it may not be recorded as such. 
Most authors divide omission errors into two and sometimes three separate categories of 
the medication-use process. Grissinger (2017), describes three main categories, prescribing 
MOEs, in which an order is not written, transcribing MOEs, in which documentation after the 
prescribing process is lost or not transferred, and admission MOEs, which occur at the sharp-end 
of service. The latter is the most common type of MOE and the focus of this article (p. 67-68).  
Lasetter et al. (2003), classified MOEs as different types of timing errors when analyzing prior 
studies, which further obfuscates generally accepted terminology when searching for this type of 
data. 
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Reporting Medication Errors 
Lastly, identification of most medication errors relies on voluntary reporting, to which 
there are many barriers (Farag, Blegen, Gedney-Lose, & Perkhounkova, 2017). The most 
common barriers are related to time constraints and punishments (Choi et al., 2016, p. 343), 
although other reasons like humiliation and retaliation from peers or superiors play a part as well 
(Farang et al., 2017). Generally, most studies agree that a just culture in an organization that 
shifts from a punitive culture increases overall voluntary reporting (Farang et al., 2017; 
Newbould et al., 2017; Wolf, 2016).  Interestingly, Tyynismaa et al. (2017), suggested that 
medication errors are rarely captured at all, with a mere 14% of all medication errors reported 
through voluntary tools (p. 7). 
The Actual Cost of Medication Omission Errors 
Costs vary widely regarding medication errors with some studies suggesting costs 
exceeding $33,000 in hospitalization costs per event if they cause an adverse medication reaction 
(Muroi, Shen, & Angosta, 2016).  In contrast, Choi et al. (2016), noted that prior studies 
estimated that medication errors could cost as little as $89 per event. Although through a robust 
analyzation of cost, they ultimately concluded that each medication error likely increases costs 
by about 8% or $7000 per hospitalization (Choi et al., 2016 p. 434). However, almost no one can 
agree on even a range of costs. 
Many authors’ focus is away from cost entirely, focusing mostly on either the causes 
and/or the prevention of the errors (Farag et al., 2017; Fitzhenry et al., 2007; McMullen et al., 
2017; Munzner, Welch & Richardson, 2012; O’Shea, Spalding & Carter, 2009). 
Complicating this issue is what constitutes costs and how they are calculated. For 
example, many studies focus on cost only if an adverse event or other complication occurred and 
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few focus on costs due to diverted resources and time to address the error itself (Choi et al., 
2016; McCarthy, Tuiskula, Driscoll & Davis, 2017). Notably, although The Joint Commission 
(2018), has recorded over 13,500 sentinel events over the last 22 years, none of the articles in 
this review discuss the cost of or feature a sentinel event, which one would assume to be the 
costliest consequence of a medication error. 
Causes of Medication Omission Errors 
 Parry, Barriball & While (2015), note that medication administration is possibly the most 
dangerous aspect of bedside nursing. Two studies highlight the vulnerability of the Registered 
Nurse (RN) at the administration end of the medication use process as nurses are the last defense 
between a patient and an incorrect medication administration (Muroi, Shen & Angosta, 2016; 
Wolf, 2016).  At the administration end of the medication use process there are a few common 
themes that contribute the most to error when it comes to nursing practice itself. These themes 
include increase in patient acuity and workload and the role of technology. 
 Many studies correlate an increase in medication errors, including omission errors, with 
an increase in patient acuity and workload (Lassetter & Warnick, 2003; Muroi, Shen & Angosta, 
2016; Newbould et al., 2017; Parry, Barriball & While, 2015; Tyynismaa et al., 2017; Wolf, 
2016).  Part of the workload distribution and acuity issues can also be linked to inadequate 
staffing and lack of experienced RN’s on a particular unit.  Scott, Considine & Botti (2014) noted 
that omission errors increased by over 19% when there were one or more unfilled nursing 
positions on just one shift in the Emergency Department. 
 The role of technology in healthcare, especially medication administration, is ever 
increasing. Many studies suggest computerized physician order entry (CPOE) also contribute 
their own errors into the medication use process through complexity of design, built-in work
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arounds, or inherent errors in the programs themselves (Fitzhenry et al., 2007, Grissinger, 2017; 
Riaz & Latif, 2017). 
Recommendations to Address Medication Omission Errors 
 Two common recommendations in literature for reducing medication errors is the need 
for some type of continuing education with or without simulation-based learning experiences 
(Muroi, Shen & Angosta, 2016; Tyynismaa et al., 2017), and the need for overall increased 
communication efforts between interdisciplinary healthcare staff (Fitzhenry et al, 2007; Lassetter 
& Warnick, 2003). Most studies recommend computerized physician order entry (CPOE) and 
barcode medication administration (BCMA) systems for reducing medication errors (Fitzhenry et 
al., 2007; Grissinger, 2017; Muroi, Shen & Angosta, 2016; Riaz & Latif, 2017). As medication 
administration becomes more complex with new delivery systems, the communication and the 
training associated with them also needs to be clear and effective. 
Discussion 
 After reviewing the literature about MOEs, several discussion points emerge, including, 
medication errors are expensive, result in real patient harm, are sometimes preventable, and have 
been an ongoing problem (Muroi, Shen & Angosta, 2016; Parry, Barriball & While, 2015).  
Despite the wide range of numbers, medication errors are costly. Even when examining the low 
range, the result annually is typically in the billions of dollars in the United States alone. These 
dollars are not just wasted from federal, insurance, and hospital dollars, but directly cost patients, 
families, and even non-profit organizations money. Like all money losing propositions, the so-
called buck is passed on to the consumer through increased taxes, insurance premiums, and out-
of-pocket expenses (McCarthy et al. 2017). 
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 Money aside, many of these MOEs result in real patient harm. This exists on a continuum 
from mild harm like increased monitoring for tachycardia, to sentinel events resulting in death or 
permanent dysfunction. There exists also the opportunity cost of missed care and earlier 
rehabilitation/recovery efforts, much of which cannot be accurately calculated as a hypothetical. 
Technically, most of these errors are preventable (Muroi, Shen & Angosta, 2016).  That is 
to say, that under the right institutional culture with adequate training, vigilance, and technology, 
the literature states that the majority of omission errors could be eliminated (Muroi, Shen & 
Angosta, 2016). 
These errors are not new, however. Neither are the reasons for their occurrence.  
Technology aside, inadequate staffing, lack of training, and poor communication are issues for 
nearly all professions. In healthcare, the stakes are higher, therefore the mistakes costlier, both in 
dollars and in human life. Despite these common recommendations for improvement there is no 
formal consensus on how to improve these chronic conditions of humanity. Much of it seems to 
drive at some impossible way to enlighten healthcare practitioners while simultaneously 
balancing the acuity of our overburdened healthcare system. These are fundamental issues which 
plague most of the healthcare industry and remain unsolved, but not for lack of effort. 
Unanswered Questions 
Is it possible that we have reached a nadir in technology and human behavior for 
reducing medication errors? Are the increases that we see in errors simply due to increased 
willingness to report errors as a result of improved just culture in organizations? After all, 
theoretically, reports of errors should increase if the literature is correct about shifting from a 
train and blame culture to a non-punitive environment (Farag et al., 2017; Lassetter & Warnick, 
2003). 
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Without some type of as-yet undiscovered paradigm shift or innovation, are humans 
doomed to repeat the same errors over and over again as part of our inherently fallible nature?  
There are thousands of articles reaching back decades discussing the same problems with 
medication errors over and over again. Even the technology we add to reduce errors contribute to 
errors themselves because they are designed and programmed by humans.   
Humans make mistakes all the time, it is part of how we learn.  Healthcare providers 
continue to take care of increasingly higher acuity patients with multiple comorbidities and 
complex courses of care. Twenty years ago, many of these comorbidities would have been 
considered end-of-life conditions. Now people can live decades with them, cheating death every 
day with modern technology and medicine. As complexity grows we open ourselves up to 
greater numbers of opportunities to make mistakes. As much as we strive for perfect care and 
good outcomes, this is not always a realistic goal. 
Also, we should never forget that dangerous things are dangerous. High-risk medications 
are dangerous by design, giving these medications to a high acuity patient makes them even 
more dangerous. Unfortunately, many healthcare providers have resigned dangerous drugs and 
situations to an unexceptional and typical status. After all, it isn’t uncommon for one patient to 
receive multiple high-risk medications at once. It isn’t even unusual for all of a nurse’s assigned 
patients in one shift to receive high-risk medications multiple times during that shift. 
Conclusion 
Continual research in this area of MOEs, perhaps examining sensitive topics such as the 
effect of ongoing litigation involving medication errors, should be pursued.  Adequate staffing 
and a balanced acuity distribution is a common-sense issue that is not so common. Decades of 
evidence support this, however, in reality this is very difficult to achieve. 
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This author suggests a three-fold strategy for combatting MOE’s: 1) Establish a non-
punitive just culture; good habits cannot blossom without a nourishing milieu, 2) Encourage an 
autodidactic ethos within your organization that includes self-reflective behaviors, and 3) Do not 
lean on technology as the last barrier between the patient and the medications they receive; a 
vigilant human eye should always be the final check.   
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